Artículos relacionados a Pharmacokinetics in Drug Development: Advances and...

Pharmacokinetics in Drug Development: Advances and Applications, Volume 3 - Tapa dura

 
9781441979360: Pharmacokinetics in Drug Development: Advances and Applications, Volume 3

Sinopsis

The topics chosen for this volume were selected because they are some of the current development or technological issues facing drug development project teams. They regard the practical considerations for assessment of selected special development populations. For example, they include characterization of drug disposition in pregnant subjects, for measuring arrhythmic potential, for analysis tumor growth modeling, and for disease progression modeling. Practical considerations for metabolite safety testing, transporter assessments, Phase 0 testing, and development and execution of drug interaction programs reflect current regulatory topics meant to address enhancement of both safety assessment and early decision-making during new candidate selection. Important technologies like whole body autoradiography, digital imaging and dried blood spot sample collection methods are introduced, as both have begun to take a more visible role in pharmacokinetic departments throughout the industry.

"Sinopsis" puede pertenecer a otra edición de este libro.

Acerca del autor

Peter Bonate has 16 years industrial experience, 13 years as a clinical pharmacologist/pharmacokineticist and 3 years in drug metabolism and bioanalysis.  He is currently a Director in the Clinical Pharmacology, Modeling, and Simulation department at GlaxoSmithKline in the oncology therapeutic area.   He has also worked at Genzyme, Hoechst Marion Roussel, Eli Lilly, and Quintiles.  He received his Ph.D. in 1996 from Indiana University in Medical Neurobiology with an emphasis on the pharmacokinetics of drugs of abuse.  He received an MS in statistics from the University of Idaho and an MS in Pharmacology from Washington State University both in 1990.  In 2003 he was elected a Fellow of the American College of Clinical Pharmacology and in 2007 was elected a fellow of the American Association of Pharmaceutical Scientists (AAPS).  He was founder of the Modeling and Simulation focus group, has served as chair of the population pharmacokinetics focus group, and was section leader for the Clinical Pharmacology and Translational Research Section within AAPS.  He has served or currently serves on the editorial boards for the Journal of Clinical Pharmacology, Pharmaceutical Research, Journal of Pharmacokinetics and Pharmacodynamics, and the AAPS Journal.  He has more than 40 publications in the field of pharmacokinetics and clinical pharmacology, is co-editor of the 2-volume series Pharmacokinetics in Drug Development published by AAPS Press in 2004, and is author of the book Pharmacokinetic-Pharmacodynamic Modeling and Simulation  published by Springer in 2005.

 

Danny Howard received his Bachelor's of Science degree in Pharmacy, and Ph.D. from the University of Missouri in Kansas City.  He began working in the pharmaceutical industry in 1991, first as a biopharmaceutics consultantand then as pharmaceutical scientist for Marion Merrell Dow, Hoechst Marion Roussel, Aventis, and Quintiles.  He is currently the Vice President of Global Pharmacokinetics and Pharmacodynamics for Novartis.  His career has included responsibilities in both clinical and nonclinical pharmacokinetics and pharmacodynamics, bioanalytics, and pharmaceutical business operations. He has worked with numerous drug submissions supporting both large and small molecules worldwide.  He was a charter member of the Missouri Biotech Association and served as its first Board Chairman.  With Peter Bonate, he was the co-editor of the series Pharmacokinetics in Drug Development published by AAPS Press in 2004.

De la contraportada

No back cover text

"Sobre este título" puede pertenecer a otra edición de este libro.

Comprar usado

Condición: Excelente
Zustand: Sehr gut | Sprache: Englisch...
Ver este artículo

EUR 105,00 gastos de envío desde Alemania a Estados Unidos de America

Destinos, gastos y plazos de envío

Comprar nuevo

Ver este artículo

EUR 8,00 gastos de envío desde Italia a Estados Unidos de America

Destinos, gastos y plazos de envío

Otras ediciones populares con el mismo título

9781489977991: Pharmacokinetics in Drug Development: Advances and Applications, Volume 3

Edición Destacada

ISBN 10:  1489977996 ISBN 13:  9781489977991
Editorial: Springer, 2016
Tapa blanda

Resultados de la búsqueda para Pharmacokinetics in Drug Development: Advances and...

Imagen de archivo

Bonate, Peter L.
Publicado por Springer, 2011
ISBN 10: 1441979360 ISBN 13: 9781441979360
Nuevo Tapa dura
Impresión bajo demanda

Librería: Brook Bookstore On Demand, Napoli, NA, Italia

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Condición: new. Questo è un articolo print on demand. Nº de ref. del artículo: cde9d778e6ea3bd1e46cdd1dc9636a9d

Contactar al vendedor

Comprar nuevo

EUR 166,29
Convertir moneda
Gastos de envío: EUR 8,00
De Italia a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: Más de 20 disponibles

Añadir al carrito

Imagen de archivo

Publicado por Springer, 2011
ISBN 10: 1441979360 ISBN 13: 9781441979360
Nuevo Tapa dura

Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Condición: New. Nº de ref. del artículo: ABLIING23Mar2411530297480

Contactar al vendedor

Comprar nuevo

EUR 203,82
Convertir moneda
Gastos de envío: EUR 3,42
A Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: Más de 20 disponibles

Añadir al carrito

Imagen del vendedor

Bonate, Peter L.|Howard, Danny R.
Publicado por Springer US, 2011
ISBN 10: 1441979360 ISBN 13: 9781441979360
Nuevo Tapa dura
Impresión bajo demanda

Librería: moluna, Greven, Alemania

Calificación del vendedor: 4 de 5 estrellas Valoración 4 estrellas, Más información sobre las valoraciones de los vendedores

Gebunden. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Provides practical guidance on the application of pharmacokinetics as a drug development scienceIncludes characterization of drug disposition in pregnant subjects, for measuring arrhythmic potential, for analysis tumor growth modeling, and for dis. Nº de ref. del artículo: 4176472

Contactar al vendedor

Comprar nuevo

EUR 180,07
Convertir moneda
Gastos de envío: EUR 48,99
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: Más de 20 disponibles

Añadir al carrito

Imagen de archivo

Peter L. Bonate
ISBN 10: 1441979360 ISBN 13: 9781441979360
Nuevo Tapa dura

Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Hardcover. Condición: new. Hardcover. The topics chosen for this volume were selected because they are some of the current development or technological issues facing drug development project teams. They regard the practical considerations for assessment of selected special development populations. For example, they include characterization of drug disposition in pregnant subjects, for measuring arrhythmic potential, for analysis tumor growth modeling, and for disease progression modeling. Practical considerations for metabolite safety testing, transporter assessments, Phase 0 testing, and development and execution of drug interaction programs reflect current regulatory topics meant to address enhancement of both safety assessment and early decision-making during new candidate selection. Important technologies like whole body autoradiography, digital imaging and dried blood spot sample collection methods are introduced, as both have begun to take a more visible role in pharmacokinetic departments throughout the industry. The topics chosen for this volume were selected because they are some of the current development or technological issues facing drug development project teams. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Nº de ref. del artículo: 9781441979360

Contactar al vendedor

Comprar nuevo

EUR 231,47
Convertir moneda
Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 1 disponibles

Añadir al carrito

Imagen del vendedor

Danny R. Howard
Publicado por Springer US Feb 2011, 2011
ISBN 10: 1441979360 ISBN 13: 9781441979360
Nuevo Tapa dura
Impresión bajo demanda

Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The topics chosen for this volume were selected because they are some of the current development or technological issues facing drug development project teams. They regard the practical considerations for assessment of selected special development populations. For example, they include characterization of drug disposition in pregnant subjects, for measuring arrhythmic potential, for analysis tumor growth modeling, and for disease progression modeling. Practical considerations for metabolite safety testing, transporter assessments, Phase 0 testing, and development and execution of drug interaction programs reflect current regulatory topics meant to address enhancement of both safety assessment and early decision-making during new candidate selection. Important technologies like whole body autoradiography, digital imaging and dried blood spot sample collection methods are introduced, as both have begun to take a more visible role in pharmacokinetic departments throughout the industry. 332 pp. Englisch. Nº de ref. del artículo: 9781441979360

Contactar al vendedor

Comprar nuevo

EUR 213,99
Convertir moneda
Gastos de envío: EUR 23,00
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 2 disponibles

Añadir al carrito

Imagen de archivo

Publicado por Springer, 2011
ISBN 10: 1441979360 ISBN 13: 9781441979360
Nuevo Tapa dura

Librería: Ria Christie Collections, Uxbridge, Reino Unido

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Condición: New. In. Nº de ref. del artículo: ria9781441979360_new

Contactar al vendedor

Comprar nuevo

EUR 226,82
Convertir moneda
Gastos de envío: EUR 13,80
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: Más de 20 disponibles

Añadir al carrito

Imagen de archivo

Unbekannt
Publicado por Springer US, 2011
ISBN 10: 1441979360 ISBN 13: 9781441979360
Antiguo o usado Tapa dura

Librería: Buchpark, Trebbin, Alemania

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Condición: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher. Nº de ref. del artículo: 9527054/12

Contactar al vendedor

Comprar usado

EUR 161,86
Convertir moneda
Gastos de envío: EUR 105,00
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 1 disponibles

Añadir al carrito

Imagen del vendedor

Danny R. Howard
Publicado por Springer US, Springer US Feb 2011, 2011
ISBN 10: 1441979360 ISBN 13: 9781441979360
Nuevo Tapa dura

Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Buch. Condición: Neu. Neuware -The topics chosen for this volume were selected because they are some of the current development or technological issues facing drug development project teams. They regard the practical considerations for assessment of selected special development populations. For example, they include characterization of drug disposition in pregnant subjects, for measuring arrhythmic potential, for analysis tumor growth modeling, and for disease progression modeling. Practical considerations for metabolite safety testing, transporter assessments, Phase 0 testing, and development and execution of drug interaction programs reflect current regulatory topics meant to address enhancement of both safety assessment and early decision-making during new candidate selection. Important technologies like whole body autoradiography, digital imaging and dried blood spot sample collection methods are introduced, as both have begun to take a more visible role in pharmacokinetic departments throughout the industry.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 332 pp. Englisch. Nº de ref. del artículo: 9781441979360

Contactar al vendedor

Comprar nuevo

EUR 213,99
Convertir moneda
Gastos de envío: EUR 60,00
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 2 disponibles

Añadir al carrito

Imagen del vendedor

Danny R. Howard
Publicado por Springer US, Springer US, 2011
ISBN 10: 1441979360 ISBN 13: 9781441979360
Nuevo Tapa dura

Librería: AHA-BUCH GmbH, Einbeck, Alemania

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The topics chosen for this volume were selected because they are some of the current development or technological issues facing drug development project teams. They regard the practical considerations for assessment of selected special development populations. For example, they include characterization of drug disposition in pregnant subjects, for measuring arrhythmic potential, for analysis tumor growth modeling, and for disease progression modeling. Practical considerations for metabolite safety testing, transporter assessments, Phase 0 testing, and development and execution of drug interaction programs reflect current regulatory topics meant to address enhancement of both safety assessment and early decision-making during new candidate selection. Important technologies like whole body autoradiography, digital imaging and dried blood spot sample collection methods are introduced, as both have begun to take a more visible role in pharmacokinetic departments throughout the industry. Nº de ref. del artículo: 9781441979360

Contactar al vendedor

Comprar nuevo

EUR 220,29
Convertir moneda
Gastos de envío: EUR 64,12
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 1 disponibles

Añadir al carrito

Imagen de archivo

Publicado por Springer, 2011
ISBN 10: 1441979360 ISBN 13: 9781441979360
Antiguo o usado Tapa dura

Librería: HPB-Red, Dallas, TX, Estados Unidos de America

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

hardcover. Condición: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority! Nº de ref. del artículo: S_352831062

Contactar al vendedor

Comprar usado

EUR 305,70
Convertir moneda
Gastos de envío: EUR 3,22
A Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 1 disponibles

Añadir al carrito

Existen otras 2 copia(s) de este libro

Ver todos los resultados de su búsqueda